DE
LLY icon

Defiance ETFs’s Eli Lilly LLY Stock Holding History

Defiance ETFs’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24M Sell
3,554
-113,289
-97% -$116M 0.06% 166
2026
Q1 		$107M Buy
+116,843
New +$118M 1.54% 11

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Defiance ETFs's LLY Position: Q2 2026 in Review

Defiance ETFs reduced its Eli Lilly (LLY) stake by 97% in Q2 2026, selling an estimated $116M and leaving 3,554 shares worth $4.24M. The position accounts for 0.06% of the portfolio, ranked #166.

Defiance ETFs first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. The position peaked at $107M in Q1 2026. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Defiance ETFs held 3,554 shares of Eli Lilly worth $4.24M as of Q2 2026.
  • Defiance ETFs sold 113,289 Eli Lilly shares in Q2 2026, an estimated $116M.
  • Eli Lilly made up 0.06% of Defiance ETFs's portfolio in Q2 2026, its #166 holding.
  • Defiance ETFs first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • Defiance ETFs's Eli Lilly position peaked at $107M in Q1 2026.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.